Protective effect of Aquilegia vulgaris L. on aflatoxin B1-induced hepatic damage in rats

Environmental Toxicology and Pharmacology

Volumn 22, Issue 1, 2006, Pages 58-63

  Jodynis Liebert, Jadwiga ^a   Matławska, Irena ^a   Bylka, Wiesława ^a   Murias, Marek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Aflatoxin B1; Aquilegia vulgaris L.; Lipid peroxidation

Indexed keywords

ACETIC ACID ETHYL ESTER; AFLATOXIN B1; ALCOHOL; ALPHA TOCOPHEROL; ANTIOXIDANT; AQUILEGIA VULGARIS EXTRACT; ASCORBIC ACID; CATALASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; IRON; PLANT EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUILEGIA; ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER INJURY; LIVER MICROSOME; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

ANIMALIA; AQUILEGIA VULGARIS;

EID: 33646818971     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2005.12.005     Document Type: Article

References (37)

1. Abdel-Wahhab M.A., and Aly S.E. Antioxidants and radical scavenging properties of vegetable extracts in rats fed aflatoxin-contaminated diet. J. Agric. Food Chem. 51 (2003) 2409-2414
2. Adamska T., Młynarczyk W., Jodynis-Liebert J., Bylka W., and Matlawska I. Hepatoprotective effect of the extract and isocytisoside from Aquilegia vulgaris. Phytother. Res. 17 (2003) 691-696
3. Amstad P., Levy A., Emerit I., and Cerutti P. Evidence for membrane-mediated chromosomal damage by aflatoxin B1 in human lymphocytes. Carcinogenesis 5 (1984) 719-723
4. Beers R.F., and Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195 (1952) 133-140
5. Bylka W. Isovitexin o-glucosides from Aquilegia vulgaris L. Acta Pol. Pharm. 58 (2001) 273-275
6. Bylka W., Frañski R., and Stobiecki M. Differentiation between isomeric acacetin-6-C-(6′′-O-malonyl)glucoside and acacetin-8-C-(6′′-O-malonyl)glucoside by using lower energy CID mass spectra. J. Mass. Spectrom. 37 (2002) 648-650
7. Bylka W., and Matlawska I. Flavonoids from Aquilegia vulgaris L. Part I. Isocytisoside and its derivatives. Acta Pol. Pharm. 54 (1997) 331-333
8. Bylka W., and Matlawska I. Flavonoids from Aquilegia vulgaris L. Part II. Derivatives of apigenin and luteolin. Acta Pol. Pharm. 54 (1997) 335-337
9. Drost-Karbowska K., Szaufer-Hajdrych M., Kowalewski Z., and Zgórka G. Phenolic acids in Aquilegia vulgaris (Ranuculaceae). Herba Polonica 42 (1996) 21-24
10. Forrester L.M., Neal G.E., Judah D.J., Glancey M.J., and Wolf C.R. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 8306-8310
11. Gallagher E.P., Kunze K.L., Stapleton P.L., and Eaton D.L. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol. Appl. Pharmacol. 141 (1996) 595-606
12. Gyamfi M.A., and Aniya Y. Medicinal herb Thonningia sanguinea protects against aflatoxin B1 acute hepatotoxicity in Fischer 344 rats. Hum. Exp. Toxicol. 17 (1998) 418-423
13. Hänsel R., Keller H., Rimpler H., and Schneider G. Bd.4 Drogen A-D. Handbuch der Pharmaceutische Praxis (1992), Berlin Heidelberg, Springer Verlag pp. 312-316
14. Jeong H.G. Inhibition of cytochrome P450 2E1 expression by oleanolic acid: hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol. Lett. 105 (1999) 215-222
15. Klein P.J., Van Vleet T.R., Hall J.O., and Coulombe R.A. Dietary butylated hydroxytoluene protects against aflatoxicosis in Turkeys. Toxicol. Appl. Pharmacol. 182 (2002) 11-19
16. Lim H.K., Kim H.S., Choi H.S., Oh S., Jang C.G., Choi J., Kim S.H., and Chang M.J. Effects of acetylbergenin against d-galactosamine-induced hepatotoxicity in rats. Pharmacol. Res. 42 (2000) 471-474
17. Liu J., Liu Y., Madhu C., and Klaassen C.D. Protective effects of oleanolic acid on acetaminophen-induced hepatotoxicity in mice. J. Pharmacol. Exp. Ther. 266 (1993) 1607-1613
18. Meki A.R., Esmail E., Hussein A.A., and Hassanein H.M. Caspase-3 and heat shock protein-70 in rat liver treated with aflatoxin B1: effect of melatonin. Toxicon 43 (2004) 93-100
19. Mohandas J., Marshall J.J., Duggin G.G., Horvath J.S., and Tiller D.J. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer Res. 44 (1984) 5086-5091
20. Nishida M., Yoshimitsu H., Okawa M., and Nohara T. Four new cycloartane glycosides from Aquilegia vulgaris and their immunosuppressive activities in mouse allogeneic mixed lymphocyte reaction. Chem. Pharm. Bull. 51 (2003) 683-687
21. Nyandieka H.S., Wakhis J., and Kilonzo M.M. Association of reduction of AFB1-induced liver tumours by antioxidants with increased activity of microsomal enzymes. Indian J. Med. Res. 92 (1990) 332-336
22. Parke D.V., and Piotrowski J.K. Glutathione: it's role in the detoxication of reactive oxygen and the environmental chemicals. Acta Pol. Toxicol. 4 (1996) 1-14
23. PDR for Herbal Medicines, 2000. Second Edition. Medical Economics Company. Montreal, New Yersey, pp. 211-212.
24. Premalatha B., and Sachdanandam P. Modulating role of Semecarpus anacardium L. nut milk extract on aflatoxin B(1) biotransformation. Pharmacol. Res. 41 (2000) 19-24
25. Rastogi R., Srivastava A.K., and Rastogi A.K. Biochemical changes induced in liver and serum of aflatoxin B1-treated male wistar rats: preventive effect of picroliv. Pharmacol. Toxicol. 88 (2001) 53-58
26. Rastogi R., Srivastava A.K., and Rastogi A.K. Long term effect of aflatoxin B(1) on lipid peroxidation in rat liver and kidney: effect of picroliv and silymarin. Phytother. Res. 15 (2001) 307-310
27. Sanz M.J., Ferrandiz M.L., Cejudo M., Terencio M.C., Gil B., Bustos G., Ubeda A., Gunasegaran R., and Alcaraz M.J. Influence of a series of natural flavonoids on free radical generating systems and oxidative stress. Xenobiotica 24 (1994) 689-699
28. Sedlak J., and Lindsay R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25 (1968) 192-205
29. Shen H.M., Shi C.Y., Lee H.P., and Ong C.N. Aflatoxin B1-induced lipid peroxidation in rat liver. Toxicol. Appl. Pharmacol. 127 (1994) 145-150
30. Souza M.F., Tome A.R., and Rao V.S. Inhibition by the bioflavonoid ternatin of aflatoxin B1-induced lipid peroxidation in rat liver. J. Pharm. Pharmacol. 51 (1999) 125-129
31. Stewart R.K., Serabjit-Singh C.J., and Massey T.E. Glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B1 in rabbit lung and liver. Toxicol. Appl. Pharmacol. 140 (1996) 499-507
32. Sun M., and Zigman S. An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation. Anal. Biochem. 90 (1978) 81-89
33. Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Rad. Biol. Med. 8 (1990) 583-599
34. Szaufer-Hajdrych M., Drost-Karbowska K., and Kowalewski Z. Phenolic acids and alkaloids in roots of Aquilegia vulgaris L. (Ranunculaceae) part IV. Herba Polonica 44 (1998) 165-171
35. Towner R.A., Qian S.Y., Kadiiska M.B., and Mason R.P. In vivo identification of aflatoxin-induced free radicals in rat bile. Free Radic. Biol. Med. 35 (2003) 1330-1340
36. Visioli F., Grande S., Bogani P., and Galli C. The role of antioxidants in the mediterranean diets: focus on cancer. Eur J. Cancer Prev. 13 (2004) 337-343
37. Williams G.M., Tanaka T., and Maeura Y. Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene. Carcinogenesis 7 (1986) 1043-1050